U.S. PHARMACOPEIA

Search USP29  
Finasteride Tablets
» Finasteride Tablets contain not less than 95.0 percent and not more than 105.0 percent of finasteride (C23H36N2O2).
Packaging and storage— Preserve in tight, light-resistant containers, and store at controlled room temperature.
Identification— The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Dissolution 711
Medium: water; 900 mL.
Apparatus 2: 50 rpm.
FOR PRODUCTS LABELED AS 5-MG TABLETS—
Time: 45 minutes.
Determine the amount of C23H36N2O2 dissolved by employing the following method.
Mobile phase— Prepare a filtered and degassed mixture of acetonitrile and water (29:21). Make adjustments if necessary (see System Suitability under Chromatography 621).
Diluting solution— Prepare a solution of acetonitrile and water (7:3).
Standard solution— Dissolve an accurately weighed quantity of USP Finasteride RS in Diluting solution, and dilute quantitatively, and stepwise if necessary, with Diluting solution to obtain a solution having a known concentration approximately equivalent to the sample under test.
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 220-nm detector and a 4.6-mm × 5-cm column that contains packing L1. The column temperature is maintained at 45. The flow rate is about 2 mL per minute. Chromatograph the Standard solution, and record the peak responses as directed for Procedure: the capacity factor, k¢, is not less than 2.0; the column efficiency is not less than 1000 theoretical plates; the tailing factor is not more than 2.0; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 200 µL) of the solution under test and the Standard solution into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity of C23H36N2O2 dissolved.
Tolerances— Not less than 75% (Q) of the labeled amount of C23H36N2O2 is dissolved in 45 minutes.
FOR PRODUCTS LABELED AS 1-MG TABLETS—
Time: 30 minutes.
Mobile phase— Prepare a degassed mixture of acetonitrile and water (11:9). Make adjustments if necessary (see System Suitability under Chromatography 621).
Diluting solution— Prepare a solution of water and acetonitrile (7:3).
Standard solution— Dissolve an accurately weighed quantity of USP Finasteride RS in Diluting solution, to obtain a solution having a known concentration of 0.1 mg per mL. Dilute this solution quantitatively, and stepwise if necessary, in 0.5% sodium lauryl sulfate to obtain a solution containing 0.001 mg of finasteride per mL.
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 220-nm detector and a 4.6-mm × 15-cm column that contains 5-µm packing L11. The column temperature is maintained at 45. The flow rate is about 1.5 mL per minute. Chromatograph the Standard solution, and record the peak responses as directed for Procedure: the column efficiency is not less than 5000 theoretical plates; the tailing factor is not more than 2.0; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 100 µL) of the solution under test and the Standard solution into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity of finasteride (C23H36N2O2) dissolved.
Tolerances— Not less than 80% (Q) of the labeled amount of C23H36N2O2 is dissolved in 30 minutes.
Uniformity of dosage units 905: meet the requirements.
Residual solvents 467: meet the requirements.
(Official January 1, 2007)
Assay—
Mobile phase— Prepare a filtered and degassed mixture of 2.5 mM phosphoric acid and acetonitrile (1:1). Make adjustments if necessary (see System Suitability under Chromatography 621).
Diluting solution— Prepare a solution of acetonitrile and water (7:3).
Standard preparation— Dissolve an accurately weighed quantity of USP Finasteride RS in Diluting solution, and dilute quantitatively, and stepwise if necessary, with Diluting solution to obtain a solution having a known concentration of about 100 µg per mL.
Assay preparation— Weigh and finely powder not fewer than 20 Tablets. Transfer an amount of powder equivalent to about 10 mg of finasteride, accurately weighed, to a 100-mL volumetric flask, dissolve in and dilute with Diluting solution to volume, and mix.
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 240-nm detector and a 4.6-mm × 10.0-cm column that contains packing L1. The column temperature is maintained at 45. The flow rate is about 1.5 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the capacity factor, k¢, is not less than 2.0; the column efficiency is not less than 1000 theoretical plates; the tailing factor is not more than 2.0; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of finasteride (C23H36N2O2) in the portion of Tablets taken by the formula:
100C(rU / rS),
in which C is the concentration, in mg per mL, of USP Finasteride RS in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Daniel K. Bempong, Ph.D., Scientist
Expert Committee : (MDPS05) Monograph Development-Pulmonary and Steroids
USP29–NF24 Page 908
Pharmacopeial Forum : Volume No. 30(5) Page 1620
Phone Number : 1-301-816-8143